Authors
Latest:
The Dawn of Scaleable Behavioral Diagnostics in Health CareThroughout the world, patients and health care professionals alike have become better acquainted with digital tools when face-to-face interactions became increasingly problematic.
Latest:
Opinion: Coronavirus Impact on Pharmacy Students in APPE RotationsThree student pharmacists share their experiences adapting to APPE rotations during the COVID-19 pandemic,
Latest:
AfrezzaNearly 30% of patients with diabetes have reported that injectable insulin was the most difficult part of their care regimen.
Latest:
How to Balance Treatment Risk, Benefit in Older Patients With CancerA standard chronological definition for older adults in oncology would be beneficial.
Latest:
Optimizing Care for Orphan Diseases With Pulmonary Issues During COVID-19 PandemicThe value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.
Latest:
Help Patients Using Opioids Avoid StigmaGiven the evidence of emotional trauma, hopelessness, and social isolation as risk factors for addiction, compassion and support are critical.
Latest:
Manufacturer Considerations for Designing a Distribution Strategy for Specialty ProductsAs health care costs continue to increase, and with high-cost specialty products making up a significant portion of the pipeline, the role of the Specialty Pharmacy (SP) continues to grow and influence health care decisions across multiple stakeholders.
Latest:
Treatment and Outcomes Data Are Evolving for Patients With COVID-19 and CancerThe CDC recommends that patients with cancer and COVID-19 have a conversation with their health care provider or care team to discuss the individual level of risk based on the patient’s current condition, treatment, and the level of transmission within their community.
Latest:
Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and OutcomesThis study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Latest:
AbbVie's New Hepatitis C Treatment Won't Cure Patient Access IssueIssues surrounding patents for curative drugs allow pharmaceutical companies to establish a market monopoly and charge astronomical prices.
Latest:
Many Options Now Available to Treat HyperlipidemiaAdherence to both pharmacologic and nonpharmacologic regimens will result in the largest impact on hyperlipidemia, and patients should be individually assessed to determine the most appropriate ones for them.
Latest:
More Than Ever, Quality Is the Name of the GameNearly 10 years ago, the Institute of Medicine made a statement that could have been read as a call to action for pharmacists.
Latest:
Celebrating 50 Years of ASHP MidyearThe American Society of Health-System Pharmacists has just finished celebrating 50 years of its Midyear Clinical Meeting.
Latest:
Serotonin and Beyond: Optimizing Management of Major Depressive DisorderPharmacists can learn about treatment of major depressive disorder.
Latest:
Medication Use in Bariatric Surgery: Evaluation of Perioperative AdjustmentsA retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.
Latest:
A Look at TCA Toxicity Presentation and TreatmentIn 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.
Latest:
Pharmacist Provider Status in Spotlight at APhA Annual MeetingA number of speakers at the American Pharmacists Association 2014 Annual Meeting in Orlando emphasized the importance of winning provider status for pharmacists.
Latest:
Examining Recent Advances in Understanding and Treatment of Dry Eye Disease: An Eye on the Pharmacist's RoleThis Continuing Education activity is supported by an educational grant from Alcon, Inc.
Latest:
Carving Out a Niche in the Treatment of Tardive DyskinesiaThe FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.
Latest:
Pharmacists and Annual Wellness VisitsPharmacists are continuing to expand their role as health care providers with more direct patient care opportunities. Pharmacists working under the supervision of a physician can provide an annual wellness visit, which is an exam that focuses on the patient’s health, allowing them the opportunity to develop a personalized approach to health care and disease prevention.
Latest:
Pharmacotherapy Timing in Heart Failure and Impact on Healthcare CostsThe findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
